Insmed Inc header image

Insmed Inc

INSM

Equity

ISIN null / Valor 12614415

NASDAQ (2026-07-28)
USD 104.13-0.57%

Insmed Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare and severe diseases, particularly targeting pulmonary conditions. The company's portfolio includes inhaled pharmaceuticals designed to treat various lung diseases, and it has expanded its pipeline through strategic acquisitions, such as Celtrix Pharmaceuticals, and partnerships like a worldwide license agreement with AstraZeneca. Following its transition to a public company, Insmed continues to advance clinical programs across its four strategic pillars, aiming to deliver meaningful clinical data and address unmet medical needs in the rare disease sector. Headquartered in Bridgewater, New Jersey, Insmed leverages its expertise and collaborative efforts to drive growth and enhance its position in the specialized pharmaceutical market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2.34%1Y
388%3Y
315%5Y

Performance

54.0%1Y
65.9%3Y
60.9%5Y

Volatility

Market cap

22570 M

Market cap (USD)

Daily traded volume (Shares)

1,945,720

Daily traded volume (Shares)

1 day high/low

69.6 / 67.75

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Orion Oyj
Orion Oyj Orion Oyj Valor: 2553367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.51%EUR 80.75
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.64%EUR 80.50
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.01%EUR 35.92
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.76%EUR 144.25
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.11%EUR 44.30
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.57%EUR 28.74
Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.29%USD 82.54
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%EUR 3.50
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%EUR 41.75
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 55.30